IN RE LIPITOR (ATORVASTATIN CALCIUM) MARKETING, SALESPRACTICES AND PRODUCTS LIABILITY LITIGATION

MDL No. 2502.

IN RE: LIPITOR (ATORVASTATIN CALCIUM) MARKETING, SALESPRACTICES AND PRODUCTS LIABILITY LITIGATION (NO. II).

United States Judicial Panel on Multidistrict Litigation.

August 12, 2014.


Attorney(s) appearing for the Case

Patricia Stark, Plaintiff, represented by Donald S. Edgar , The Edgar Law Firm & Jeffrey Rex Grady , The Edgar Law Firm.

Pfizer, Defendant, represented by Karin A. Kramer , Quinn Emanuel Urquhart & Sullivan, LLP.

McKesson, Defendant, represented by Emma Elizabeth Garrison , Wheeler Trigg O'Donnell LLP.

Before: Marjorie O. Rendell, Charles R. Breyer, Lewis A. Kaplan, Sarah S. Vance, R. David Proctor.


TRANSFER ORDER

JOHN G. HEYBURN, II, Chairman.

Before the Panel:* Pursuant to Panel Rule 7.1, plaintiffs in three actions move to vacate our orders conditionally transferring the actions to the District of South Carolina for inclusion in MDL No. 2502. Defendant Pfizer Inc. opposes the motions.1 The actions, which are listed on the attached Schedule A, are pending in the Central District...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases